April 11 (Reuters) - MorphoSys AG:
* MORPHOSYS AG - NOVARTIS OFFERS EUR 68.00 PER SHARE IN
CASH,
REPRESENTING A TOTAL EQUITY VALUE OF EUR 2.7 BILLION
* MORPHOSYS AG - MORPHOSYS' MANAGEMENT BOARD AND SUPERVISORY
BOARD
RECOMMEND SHAREHOLDERS ACCEPT PUBLIC TAKEOVER OFFER BY NOVARTIS
* MORPHOSYS AG - ACCEPTANCE PERIOD HAS COMMENCED AND WILL
END ON
MAY 13, 2024
* MORPHOSYS AG: MAINTAIN EXPECTATION THAT CLOSING OF
TAKEOVER
OFFER WILL TAKE PLACE IN FIRST HALF OF 2024
Source text for Eikon:
Further company coverage: